Clorox (CLX) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Clorox (NYSE: CLX) recently:

  • 5/14/2023 – Clorox had its price target raised by analysts at Barclays PLC from $118.00 to $124.00.
  • 5/4/2023 – Clorox had its price target raised by analysts at Barclays PLC from $113.00 to $118.00.
  • 5/3/2023 – Clorox had its price target raised by analysts at Bank of America Co. from $130.00 to $140.00.
  • 5/3/2023 – Clorox had its price target raised by analysts at Wells Fargo & Company from $145.00 to $150.00.
  • 5/3/2023 – Clorox had its price target raised by analysts at UBS Group AG from $148.00 to $162.00.
  • 5/3/2023 – Clorox had its price target raised by analysts at Raymond James from $165.00 to $185.00.
  • 5/3/2023 – Clorox had its price target raised by analysts at Royal Bank of Canada from $137.00 to $151.00.
  • 4/29/2023 – Clorox was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
  • 4/21/2023 – Clorox was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
  • 4/18/2023 – Clorox had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $147.00 to $149.00.
  • 4/14/2023 – Clorox had its price target raised by analysts at Barclays PLC from $108.00 to $113.00. They now have an “underweight” rating on the stock.
  • 4/12/2023 – Clorox had its price target raised by analysts at Wells Fargo & Company from $135.00 to $145.00. They now have an “underweight” rating on the stock.
  • 4/6/2023 – Clorox had its price target raised by analysts at UBS Group AG from $140.00 to $148.00. They now have a “sell” rating on the stock.
  • 3/20/2023 – Clorox had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $152.00 to $147.00.

Clorox Stock Performance

Shares of Clorox stock opened at $166.98 on Thursday. The Clorox Company has a one year low of $120.50 and a one year high of $178.21. The company has a market cap of $20.64 billion, a PE ratio of 287.90, a P/E/G ratio of 3.02 and a beta of 0.30. The company has a debt-to-equity ratio of 14.40, a quick ratio of 0.51 and a current ratio of 0.87. The business has a 50-day simple moving average of $160.77 and a 200-day simple moving average of $151.74.

Clorox (NYSE:CLXGet Rating) last announced its quarterly earnings data on Tuesday, May 2nd. The company reported $1.51 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.29. Clorox had a return on equity of 114.67% and a net margin of 1.03%. The business had revenue of $1.92 billion during the quarter, compared to the consensus estimate of $1.82 billion. During the same period in the previous year, the company posted $1.31 earnings per share. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 4.47 EPS for the current fiscal year.

Institutional Investors Weigh In On Clorox

Institutional investors have recently added to or reduced their stakes in the business. Dark Forest Capital Management LP purchased a new stake in Clorox during the fourth quarter worth approximately $28,000. Hallmark Capital Management Inc. purchased a new stake in Clorox in the third quarter valued at approximately $29,000. OLD Mission Capital LLC purchased a new stake in Clorox in the fourth quarter valued at approximately $29,000. Delta Asset Management LLC TN purchased a new stake in Clorox in the fourth quarter valued at approximately $31,000. Finally, Ten Capital Wealth Advisors LLC lifted its stake in Clorox by 429.7% in the first quarter. Ten Capital Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $31,000 after buying an additional 159 shares during the last quarter. Hedge funds and other institutional investors own 79.12% of the company’s stock.

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Recommended Stories

Receive News & Ratings for The Clorox Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox Company and related companies with MarketBeat.com's FREE daily email newsletter.